Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 447

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A department of veterans affairs cooperative study

Clegg, Daniel O., Reda, Domenic J., Mejias, Edwin, Cannon, Grant W., Weisman, Michael H., Taylor, Thomas, Budiman‐Mak, Elly, Blackburn, Warren D., Vasey, Frank B., Mahowald, Maren L., Cush, John J., Schumacher, H. Ralph, Silverman, Stuart L., Alepa, F. Paul, Luggen, Michael E., Cohen, Miriam R., Makkena, Rama, Haakenson, Clair M., Ward, Richard H., Manaster, B. J., Anderson, Robert J., Ward, John R., Henderson, William G.·1996·Arthritis & Rheumatism

Abstract

Objective. To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is effective for the treatment of active psoriatic arthritis (PsA) resistant to nonsteroidal antiinflammatory drug therapy. Methods. Two hundred twenty‐one patients with PsA were recruited from 15 clinics, randomized (double‐blind) to SSZ or placebo treatment, and followed up for 36 weeks. Treatment response was based on joint pain/tenderness and swelling scores and physician and patient global assessments. Results. Longitudinal analysis revealed a trend favoring SSZ treatment (P = 0.13). At the end of treatment, response rates were 57.8% for SSZ compared with 44.6% for placebo (P = 0.05). The Westergren erythrocyte sedimentation rate declined more in the PsA patients taking SSZ than in those taking placebo (P < 0.0001). Adverse reactions were fewer than expected and were mainly due to nonspecific gastrointestinal complaints, including dyspepsia, nausea, vomiting, and diarrhea. Conclusion. SSZ at a dosage of 2,000 mg/day is well tolerated and may be more effective than placebo in the treatment of patients with PsA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.1780391210

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 447

Metadata

Authors
Clegg, D. O., Reda, D. J., Mejias, E., Cannon, G. W., Weisman, M. H., Taylor, T., Budiman‐Mak, E., Blackburn, W. D., Vasey, F. B., Mahowald, M. L., Cush, J. J., Schumacher, H. R., Silverman, S. L., Alepa, F. P., Luggen, M. E., Cohen, M. R., Makkena, R., Haakenson, C. M., Ward, R. H., Manaster, B. J., Anderson, R. J., Ward, J. R., & Henderson, W. G.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
1996-12
Volume
39
Issue
12
Pages
2013-2020
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W1976217778
Cited by
447
References
6
FWCI
2.95
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A department of veterans affairs cooperative study. https://app.cochat.ai/papers/10.1002/art.1780391210
The paper
Clegg, D. O., Reda, D. J., Mejias, E., Cannon, G. W., Weisman, M. H., Taylor, T., Budiman‐Mak, E., Blackburn, W. D., Vasey, F. B., Mahowald, M. L., Cush, J. J., Schumacher, H. R., Silverman, S. L., Alepa, F. P., Luggen, M. E., Cohen, M. R., Makkena, R., Haakenson, C. M., Ward, R. H., . . . Henderson, W. G. (1996). Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A department of veterans affairs cooperative study. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780391210

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.